ストックスクリーナーアプリを入手
9.75
1.02%
-0.10
プレマーケット:
9.75
前日終値:
$9.85
開ける：
$9.87
24時間の取引高:
153.63K
Relative Volume:
1.43
時価総額：
$140.58M
収益：
$166.88M
当期純損益:
$-74.18M
株価収益率:
-1.9231
EPS:
-5.07
ネットキャッシュフロー:
$1.14M
1週間 パフォーマンス:
-0.31%
1か月 パフォーマンス:
+5.29%
6か月 パフォーマンス:
-30.75%
1年 パフォーマンス:
-43.54%
1日の値動き範囲:
$9.4051
$9.87
1週間の範囲:
$9.4001
$10.75
52週間の値動き範囲:
$7.8701
$18.37
Anika Therapeutics Inc Stock (ANIK) Company Profile
名前
Anika Therapeutics Inc
セクター
電話
(781) 457-9000
住所
32 WIGGINS AVENUE, BEDFORD, MA
ANIK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.75 | 142.02M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
119.56 | 53.10B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.64 | 42.93B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.41 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.46 | 28.22B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
454.00 | 19.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-17 | 開始されました | B. Riley Securities | Buy |
| 2024-11-01 | 繰り返されました | Barrington Research | Outperform |
| 2023-08-14 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | 再開されました | Stephens | Equal-Weight |
| 2022-03-09 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | 開始されました | Stephens | Overweight |
| 2021-07-16 | 開始されました | UBS | Neutral |
| 2020-12-16 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | アップグレード | Sidoti | Neutral → Buy |
| 2020-01-10 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | 開始されました | BWS Financial | Sell |
| 2019-09-24 | 繰り返されました | Barrington Research | Outperform |
| 2019-09-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | ダウングレード | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2018-07-27 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | 繰り返されました | Barrington Research | Outperform |
| 2016-05-09 | アップグレード | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Anika Therapeutics Inc (ANIK) 最新ニュース
Will Anika Therapeutics Inc. stock reach all time highs in 2025Gap Down & Long-Term Investment Growth Plans - newser.com
Is Anika Therapeutics Inc. stock undervalued vs historical averagesPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... By GuruFocus - Investing.com Canada
Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... - Yahoo Finance
Anika Therapeutics (ANIK) Rating Maintained, Price Target Raised by Barrington Research | ANIK Stock News - GuruFocus
Why Anika Therapeutics Inc. stock could outperform in 2025Stop Loss & High Accuracy Trade Signal Alerts - newser.com
Anika outlines 12%–18% commercial channel revenue growth for 2025 while advancing Integrity and regulatory milestones - MSN
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2025 Earnings Call Transcript - Insider Monkey
Using AI based signals to follow Anika Therapeutics Inc.2025 Macro Impact & Safe Entry Momentum Stock Tips - newser.com
Does Anika Therapeutics Inc. show high probability of reboundJuly 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Anika: Q3 Earnings Snapshot - CT Insider
Will Anika Therapeutics Inc. (AKP) stock announce special dividendMarket Trend Review & Fast Momentum Stock Entry Tips - fcp.pa.gov.br
Strategies to average down on Anika Therapeutics Inc.2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Detecting support and resistance levels for Anika Therapeutics Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
How to escape a deep drawdown in Anika Therapeutics Inc.2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Anika Therapeutics Reports Mixed Q3 2025 Results - TipRanks
Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates - sharewise.com
Anika Therapeutics (ANIK) Trades Below Fair Value; Valuation Discount Reinforces Cautious Market Narratives - Yahoo Finance
Is Anika Therapeutics Inc. stock trading at a premium valuationJuly 2025 Rallies & Reliable Trade Execution Plans - fcp.pa.gov.br
Why Anika Therapeutics Inc. stock could rally in 2025July 2025 Earnings & Daily Risk Controlled Trade Plans - newser.com
Anika Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks
[S-8] Anika Therapeutics, Inc. Employee Benefit Plan Registration | ANIK SEC FilingForm S-8 - Stock Titan
[10-Q] Anika Therapeutics, Inc. Quarterly Earnings Report | ANIK SEC FilingForm 10-Q - Stock Titan
Transcript : Anika Therapeutics, Inc., Q3 2025 Earnings Call, Nov 05, 2025 - MarketScreener
Anika Therapeutics, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:ANIK) 2025-11-05 - Seeking Alpha
Anika Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Anika Therapeutics Beats Revenue Estimates Despite Slump In Sales - Finimize
Earnings call transcript: Anika Therapeutics Q3 2025 sees unexpected EPS rise - Investing.com
Anika (ANIK) Q3 2025 Earnings Call Transcript - The Motley Fool
Will Anika Therapeutics Inc. (AKP) stock benefit from infrastructure billMarket Trend Summary & High Conviction Buy Zone Picks - fcp.pa.gov.br
Anika (ANIK) Keeps 2025 Revenue Forecasts Steady Across Channels - GuruFocus
Anika Therapeutics Q3 2025 Earnings: EPS of -$0.22 Beats Estimat - GuruFocus
Anika Therapeutics Files Final Module for Hyalofast - TipRanks
[8-K] Anika Therapeutics, Inc. Reports Material Event | ANIK SEC FilingForm 8-K - Stock Titan
Anika Reports Third Quarter 2025 Financial Results - The Manila Times
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study - The Manila Times
Anika Therapeutics Reports Third Quarter 2025 Results: Commercial Channel Revenue Increases 22% Amid Strategic Developments - Quiver Quantitative
BRIEF-Anika Therapeutics Q3 Revenue USD 27.817 Million - TradingView
Anika Therapeutics Reports Filing of Final PMA Module for - GlobeNewswire
Published on: 2025-11-05 04:05:30 - newser.com
Key metrics from Anika Therapeutics Inc.’s quarterly dataTrade Performance Summary & Low Volatility Stock Suggestions - newser.com
How strong is Anika Therapeutics Inc. stock balance sheetPortfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 2025 - newser.com
What dividend safety rating applies to Anika Therapeutics Inc. (AKP) stockJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: W - GuruFocus
Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Orthopedic Regenerative Medicine with Detailed Study Analysis 2025-2032 | Anika Therapeutics, Inc and Arthrex - openPR.com
Is Anika Therapeutics Inc. stock supported by strong cash flowsJobs Report & Free Accurate Trade Setup Notifications - newser.com
Anika Therapeutics Inc (ANIK) 財務データ
収益
当期純利益
現金流量
EPS
Anika Therapeutics Inc (ANIK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
5.05%
0.52%
大文字化:
|
ボリューム (24 時間):